IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 3568 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  NAVIGATE Here 
    Next article
    Previous article
    Table of Contents

 RESOURCE Links
    Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1286    
    Printed20    
    Emailed0    
    PDF Downloaded2    
    Comments [Add]    

Recommend this journal

 

 ORIGINAL CONTRIBUTION
Year : 1988  |  Volume : 54  |  Issue : 1  |  Page : 27--29

Evaluation Of-astemizole- A New H-1 Blocking Antihistamine in Urticaria



Correspondence Address:
Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 28134173

Rights and PermissionsRights and Permissions

An open trial of astemizole a new anthistamine on 30 patients, having urticaria revealed complete relief in 28 patients. The controlling daily dose was 10 mg in 17 patients, 20 mg in 7 and 30 mg in 4. Two patients did not improve even with 40 mg a day given for 7 days. The side effects included mild sedation in 7, dryness of mouth in 3 and constipation in 2 on a dose of 20 or 30 mg a day. Laboratory parameters remained almost normal.






[PDF]*


        
Print this article     Email this article

Online since 15th March '04
Published by Wolters Kluwer - Medknow